Biochemia Medica


THE JOURNAL OF CROATIAN SOCIETY FOR MEDICAL BIOCHEMISTRY AND LABORATORY MEDICINE

ČASOPIS HRVATSKOG DRUŠTVA ZA MEDICINSKU BIOKEMIJU I LABORATORIJSKU MEDICINU

UDC 577.1 ISSN 1849-820

11th Congress of the Croatian Society of Medical Biochemistry and Laboratory Medicine with international participation


Vodice, Croatia, 9-12 October 2024


Organizer
Croatian Society of Medical Biochemistry and Laboratory Medicine


Auspices
President of the Republic of Croatia
International Federation of Clinical Chemistry and Laboratory Medicine – IFCC
Ministry of Health of the Republic of Croatia
European Federation of Clinical Chemistry and Laboratory Medicine – EFLM
University of Zagreb
Faculty of Pharmacy and Biochemistry


Scientific Committee
Ivana Ćelap, president
Lovorka Đerek
Marija Grdić Rajković
Mirjana Mariana Kardum Paro
Sanja Mandić
Domagoj Marijančević
Daniela Šupe-Domić
Sandra Šupraha Goreta
Jelena Vlašić Tanasković
Jasenka Wagner Kostadinović


Organizing Committee
Jelena Culej, president
Marina Čeprnja
Petra Dumanić
Željka Kelava
Iva Lukić
Lara Milevoj Kopčinović
Antonija Perović
Anita Radman
Anita Somborac Bačura


Congress Secretariat
Jasna Đogić, secretary
Croatian Society of Medical Biochemistry and Laboratory Medicine
Boškovićeva 18
10000 Zagreb, Croatia
tel/fax: +385 1 48 28 133

 

Contents


Pre-congress symposium 5


PCS-1 Optimization of the continuous control model using patients results – The experience of a large laboratory 5
PCS-2 Application of moving average procedures for continuous quality control in small laboratories 6
PCS-3 Patient-based external quality assessment in medical laboratories 7
PCS-4 Challenges in establishing indirect reference intervals 8
PCS-5 Big data, machine learning and artificial intelligence 9
PCS-6 Information technologies in the service of the medical biochemist 10


Plennary lecture 12


PL-1 Management of a modern laboratory 12
PL-2 Decision-making 13
PL-3 Artificial intelligence in scientific publishing 14


Symposium lectures 15


S1 Clinical and diagnostic monitor
ing of lymphoproliferative diseases 15
S2 Diabetes and insulin resistance; challenges in diagnostics and science 22
S3 Challenges of laboratory diagnosis of preeclampsia 27
S4 Biological therapy from a clinical and laboratory perspective 32
S5 Challenges of biomarker application in cardiometabolic diseases 38
S6 New insights into metabolic diseases 44


Working groups sessions 49


WG-1 Working group for seminal fluid 49
WG-2 Working group for post-analytics 51
WG-3 Working group for cerebrospinal fluid diagnostics 53
WG-4 Working group for laboratory coagulation 55


Poster abstracts 57


A Hematology 57
B Hemostasis 73
C Cardiovascular Diseases 76
D Endocrinology 78
F Chronic Diseases 86

G Autoimmune Diseases 90

H Nutrition 95
I Infectious Diseases and COVID-19 97
J Pediatric laboratory medicine 99
L Molecular diagnostics 101
M POCT 104
O New Biomarkers 107
P New Technologies 111
R Case Report 112
U Laboratory Management 127
V Management in the Health Care System 129
Z Other 13